C. Power et al., Proinflammatory effects of bacterial lipoprotein on human neutrophil activation status, function and cytotoxic potential in vitro, SHOCK, 15(6), 2001, pp. 461-466
Citations number
33
Categorie Soggetti
Aneshtesia & Intensive Care","Cardiovascular & Hematology Research
Bacterial lipoprotein (BLP) is the most abundant protein in gram-negative b
acterial cell walls, heavily outweighing lipopolysaccharide (LPS). Herein w
e present findings demonstrating the potent in vitro effects of BLP on neut
rophil (PMN) activation status, function, and capacity to transmigrate an e
ndothelial monolayer. PMNs are the principal effecters of the initial host
response to injury or infection and constitute a significant threat to inva
ding bacterial pathogens. The systemic inflammatory response syndrome (SIRS
) is characterised by significant host tissue injury mediated, in part, by
uncontrolled regulation of PMN cytotoxic activity. We found that BLP-activa
ted human PMN as evidenced by increased CD11b/CD18 (Mac-1) expression. Up-r
egulation of PMN Mac-1 in response to BLP occurred independently of membran
e-bound CD14 (mCD14). A similar up-regulation of intercellular adhesion mol
ecule-1 (ICAM-1) on endothelial cells was observed whilst E-Selectin expres
sion was unaffected. PMN transmigration across a human umbilical vein endot
helial cell (HUVEC) monolayer was markedly increased after treating either
PMN's or HUVEC independently with BLP. This increased transmigration did no
t occur as a result of any direct effect of BLP on HUVEC monolayer permeabi
lity, assessed objectively using the passage of FITC-labeled Dextran-70. BL
P primed PMN for enhanced respiratory burst and superoxide anion production
in response to PMA, but did not influence phagocytosis of opsonized Escher
ichia coil. BLP far exceeds LPS as a gram-negative bacterial wall component
, these findings therefore implicate BLP as an additional putative mediator
of SIRS arising from gram-negative infection.